摘要
目的研究肺泡表面活性物质(PS)联合经鼻持续气道正压通气(NCPAP)对于小儿急性呼吸窘迫综合征(ARDS)患儿的作用与效果。方法选出我院接受并治疗的84例ARDS病例,纳入的时间段最开始由2017年10月至2019年11月,把PS的42例作为A组,把PS联合NCPAP的42例作为B组,观察比较其结果。结果在治疗后,B组患儿各项血气分析指标对比A组患儿更优,具有显著性的差异(P<0.05);在治疗后,B组患儿治疗疗效对比A组患儿更高,具有显著性的差异(P<0.05)。结论对于小儿ARDS患儿,PS联合NCPAP效果颇为显著,建议临床推崇使用。
Objective To study the effects and effects of alveolar surfactant(PS)combined with nasal continuous positive airway pressure(NCPAP)on children with acute respiratory distress syndrome(ARDS).Methods Eighty-four ARDS cases received and treated in our hospital were selected.The period of inclusion was from October 2017 to November 2019.42 cases of PS were taken as group A,and 42 cases of PS combined with NCPAP were taken as Group B,then observed and compared the results of them.Results After treatment,the blood gas analysis indexes of group B were better than those of group A,with significant differences(P<0.05).After treatment,the treatment effect of group B was better than that of group A.Which with a significant difference(P<0.05).Conclusion For children with ARDS,the effect of PS combined with NCPAP is quite significant,and it is recommended to use it clinically.
作者
张经
罗永奇
庞详华
ZHANG Jing;LUO Yong-qi;PANG Xiang-hua(Department of Pediatrics,Leizhou People’s Hospital of Guangdong Province,Leizhou,Guangdong 524200)
出处
《智慧健康》
2020年第16期122-123,140,共3页
Smart Healthcare
